Skip to main content
logo
Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.6915
-0.0335 (-4.62%)
Sep 1, 2026, 4:00 PM EDT - Market closed

Estrella Immunopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Jun '24 Jun '23 Jun '22
Net Income
-10.01-13.06-8.85-7.31-11.11-1.69
Stock-Based Compensation
0.590.620.431.190.410.13
Other Operating Activities
0.370.04----
Change in Accounts Payable
00.55-0.07-9.338.39-
Change in Income Taxes
--0-0.04---
Change in Other Net Operating Assets
-0.3310.070.89-0.620.980.11
Operating Cash Flow
-9.38-1.79-7.64-16.07-1.34-1.44
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Jun '24 Jun '23 Jun '22
Other Investing Activities
---4.96-0.27-
Investing Cash Flow
---4.96-0.27-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
---0.3--
Total Debt Issued
---0.3--
Short-Term Debt Repaid
----0.3--
Total Debt Repaid
----0.3--
Issuance of Common Stock
9.052.40.0810-0.02
Repurchase of Common Stock
--0.03-0.57-5.43--
Other Financing Activities
-0.84-0.12--0.8-0.52
Financing Cash Flow
8.212.25-0.4912.79-5.53

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Jun '24 Jun '23 Jun '22
Net Cash Flow
-1.170.47-8.131.69-1.614.09

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Jun '24 Jun '23 Jun '22
Levered Free Cash Flow
-6.793.43--12.952.81-
Unlevered Free Cash Flow
-6.793.43--12.952.81-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Jun '24 Jun '23 Jun '22
Cash Interest Paid
---0--
Cash Income Tax Paid
000.040--
Change in Working Capital
-0.3310.620.78-9.959.370.11
SEC Filings: 10-K · 10-Q